striatum. In these areas, the majority of APP-immuno reactive cells were reactive glial fibrillary acidic protein (GFAP)-positive astrocytes, as shown by double-im munofluorescence labeling for GFAP and APP. Addition ally, small ramified cells, most likely activated microglia, expressed APP immunoreactivity. In contrast, in the pa rietal cortex, APP immunoreactivity occurred focally in clusters of activated microglia rather than in astrocytes, as demonstrated by double-immunofluorescence labeling for APP and the microglia-binding lectin Griffonia sim plicifolia isolectin B4• In conclusion, following global ischemia, APP is induced in reactive glial cells with spa tial differences in the distribution pattern of APP induc tion in astrocytes and microglia. Key Words: Alzheimer's disease-f3-Amyloid precursor protein-Astrocytes Global ischemia-Microglia-Neurodegeneration.
APP immunoprecipitated from total normal brain is derived from neurons and lacks the KPI domain. Under pathological conditions (Tanaka et aI. , 1989; Roberts et aI. , 1991; Johnson et aI. , 1993) and in most experimental lesion models (Abe et a!. , 1991; Karawabayashi et a!. , 1991; Banati et a!. , 1993b) , however, the primarily nonneuronal KPI-contain ing APP isoforms (Weidemann et aI. , 1989; Ohyagi et a!. , 1990; Paul et a!. , 1992) are up-regulated. Fur thermore, APP has been detected directly in differ ent glial cell types in vivo and in vitro (Haass et a!. , 1991; Konig et aI. , 1992; Palacios et a!. , 1992; Ba nati et a!. , 1993b Ba nati et a!. , , 1994 , suggesting, in addition to neurons, a glial origin of APP in the lesioned brain. The present study investigates immunocytochemi cally the expression of glial APP in different ana tomical regions and at different time points after global cerebral ischemia. The four-vessel occlu s ion model used here (Pulsinelli and Brierley, 1979; Schmidt-Kastner et a!. , 1989 leads to neuro nal degeneration in the dorsolateral striatum within 12 h, while the neuronal degeneration in the hippo campal CAl region occurs with a characteristic de lay of 2-3 days. Within the cortical layers III, IV, and VI, the postischemic neuronal damage is less pronounced, affecting only disseminated cells. We were therefore interested in whether these regional differences might affect the extent and cellular lo calization of APP expression.
MATERIALS AND METHODS
A 30-min global ischemia was achieved with the four vessel occlusion described by Pulsinelli and Brierley (1979) , as modified by Schmidt-Kastner et al. (1989) . Adult male Wistar rats weighing 200-350 g were anesthe tized with halothane/nitrous oxide. On the first day, both vertebral arteries were coagulated, followed on the sec ond day by the occlusion of both common arteries for 30 min under continuous EEG recording. Only animals showing complete EEG flattening during the four-vessel occlusion were used. After removal of the vessel occlu sion, free blood circulation was ascertained by micro scopic examination of the carotid arteries. Mortality of recirculated animals was 6.7% with no prevalence for any survival period. Convulsions were rarely observed «3%), but, if occurring, the affected animals were ex cluded from the experimental group. One animal for each studied survival time was sham operated; i.e., both ver tebral arteries were coagulated and the carotid arteries exposed, but not occluded. The postischemic brains were removed after the following survival times: 12 h, 1, 2, 3, and 7 days. The brains were rapidly frozen in nitrogen precooled isopentane and stored at -80°C until further analysis. Ten-micron coronal serial sections were cut at the level of the rostral striatum and the dorsal hippocam pus and mounted on polY-L-lysine-coated slides. For im munocytochemistry, sections were air dried, fixed for 5 min in 3.7% formalin and then in acetone (2 min 50%, 2 min 100%, 2 min 50%). After rehydration in 0.1 M phos phate-buffered saline (pH 7.4), the sections were blocked for 30 min with 2% normal horse serum. They were then incubated overnight at 4°C, with either the 22C11 mouse monoclonal antibody (1 : 100; Boehringer, Ingelheim, Ger many) that specifically recognizes an epitope between residues 66 and 81 of the APP (Weidemann et al., 1989; Hilbich et al., 1993) or the 2.F2.18B4/APP 643-695/Jonas mouse monoclonal antibody (1 :80; Boehringer) against the cytoplasmic carboxyl fragment of APP 643-695. Antibody detection was carried out using a biotinylated horse anti mouse secondary antibody (Serotec, Oxford, U.K.) and the Vectastain ABC-Elite kit (Vector, Burlingame, CA, U.S.A.) with 3,3'-diaminobenzidine as peroxidase sub strate. Counterstaining was performed with cresyl violet.
For double-immunofluorescence labeling of APP and glial fibrillary acidic protein (GFAP), sections were first incubated with the 22Cll antibody, which was detected using the biotinylated horse anti-mouse antibody, fol lowed by cyanine 3. 18-conjugated streptavidin (Dianova, Hamburg, Germany), according to the protocol by Wes sendorf and Brelje (1992) . The sections were then incu bated with a polyclonal anti-GFAP antibody (1:400; Dako, Hamburg, Germany), followed by a fluorescein isothiocyanate (FITC)-conjugated anti-rabbit antibody (Dianova). For double-immunofluorescence labeling of J Cereb Blood Flow Metab. Vol. 15. No. 4. 1995 APP and the microglia-binding B4 isolectin from Griffonia simplicifolia (GSI-B4) (Streit and Kreutzberg, 1987) , the sections were first incubated with the 22Cll anti-APP anti body, followed by an anti-mouse FITC-Iabeled secondary antibody (Dianova). They were then incubated with GSI-B4 (Sigma, Munich, Germany) at a concentration of 10 /J-gIrnl, followed by a biotinylated anti-GSI-B4 antibody (Vector Labs.) and the cyanine 3. 18-conjugated streptavidin. In this case, cyanine 3.18 was chosen as the brightest fluoro chrome available (Wessendorf and Brelje, 1992) to mark edly enhance the sensitivity of the microglial lectin staining.
RESULTS

Dorsal hippocampus
In the sham-operated animals, the non neuronal APP immunoreactivity was confined to blood ves sels, ependymal cells, and Bergmann glia. In the walls of small blood vessels, constitutive expres sion of APP was particularly prominent in perivas cular cells, as described earlier (Banati et aI., 1993b) . Otherwise, no APP-immunoreactive glial cells were observed in normal brains. Neuronal APP immunoreactivity was detected in the cyto plasm of neurons as a punctate staining, possibly suggesting a localization of the epitope on the Golgi apparatus (see Fig. lA ).
From 48 h after global ischemia onward, neuronal damage in the dentate hilus of the dorsal hippocam pus was discernible by the Nissl and hematoxylin eosin staining. At these early time points, however, no up-regulation of APP in glial cells was seen ( Fig.  2A ). The first APP-immunoreactive cells were seen in CAl with a delay of 48 h following ischemia. At day 3 after ischemia, the pyramidal neurons of CAl were lost and a massive induction of APP immunoreactivity on astrocytes and microglia oc curred (Fig. 2B ). The transition zone from CAl to CA3 was characterized by the sharp contrast be tween increased APP immunoreactivity in CAl and relatively little APP immunoreactivity in CA3. Within the CAl region, the strongest glial APP im munoreactivity was found in the stratum pyrami dale ( Fig. 2B and E) and to a lesser extent in the stratum oriens ( Fig. 2D ) and stratum lacunosum moleculare. Within the CAl region, this glial up regulation of APP immunoreactivity further in creased and was extended until day 7, the latest time point examined (Fig. 2C ). In all animals with survival times of 3 and 7 days, the observed degen eration of CAl pyramidal neurons correlated with the increase in glial APP immunoreactivity. Three days after ischemia, the CA4 region also contained a small number of APP-immunopositive cells. In the CA3 region at day 7, glial cells expressing A " PP were rare and absent in the stratum moleculare of the dentate gyrus. Morphologically, the majority of APP-immunoreactive cells in the various hippocam-pal regions resembled hypertrophic, reactive astro cytes, as confirmed by double labeling with GFAP and APP ( Fig. 3A and B) . A smaller number of GFAP-negative microglia, particularly in the stra tum oriens, were also expressing APP (Fig. 2D ). There was no marked difference in the time of onset of the de novo APP expression in microglia com pared with astrocytes. In both sham-operated and postischemic brains, a patchy cytoplasmic staining for APP could be detected in neurons. A clearly discernible postischemic increase in the neuronal staining could, however, not be observed. Also, no indication of an expression of APP in oligodendro cytes was found in the postischemic brain areas studied, i. e. , hippocampus, dorsolateral striatum, and parietal cortex. Both monoclonal antibodies, 22C ll and 2. F2. 18B4/APP 643-695/Jonas, yielded similar staining patterns in normal as well as post ischemic brain (Fig. lB) . 
Dorsolateral striatum
Twelve hours after global ischemia, neuronal damage in the dorsolateral striatum was visible by Nissl and hematoxylin--eosin staining. At these early time points, however, no up-regulation of APP in glial cells was seen. In the dorsolateral striatum at days 3 and 7 after ischemic lesion, immunoreactivity for APP was strongly induced in glial cells, preferen tially in the border zone of the striatum to the sur rounding tissue. Thus, despite the earlier onset of neuronal degeneration in the dorsolateral striatum, APP immunoreactivity in glial cells occurred with the same delay seen in the hippocampus. As in the hippocampus, APP expression was most prominent in hypertrophic astroglia, though APP-immuno reactive microglia were also frequent ( Fig. 4) . W ith respect to the time points when the first APP im munoreactivity became detectable, microglia did not seem to express APP earlier than astrocytes.
FIG. 2. Glial [13-amyloid precursor protein] (APP) expression in hippocampus (mouse monoclonal antibody 22C11). A:
At 24 h after global ischemia, no up-regulation of APP in glial cells was seen. B: At day 3 after ischemia, a massive induction of APP immunoreactivity on astrocytes and microglia occurred. The strongest glial APP immunoreactivity within the CA1 region was found in the stratum pyramidale (arrows) and to a lesser extent in the stratum oriens and stratum lacunosum-moleculare. C: At day 7, APP immunoreactivity was further increased. The arrows point to prominent hypertrophic astrocytes in the stratum pyramidale. D: Microglia (arrows) expressing APP were found particularly in the stratum oriens (here, at day 7). E: Hypertrophic, reactive astrocytes (arrows) were localized mostly in the striatum pyramidale. Bar (A-C) = 50 ILm; bar (0 and E) = 16 ILm.
Parietal cortex
Clusters of APP-immunoreactive cells were ob served in the parietal cortex at days 3 and 7. Double immunofluorescence clearly showed that these APP-immunoreactive cells were almost exclusively GSI-B4-positive microglia ( Fig. 3C and D) . Each of these focal clusters typically consisted of 10-20 APP-immunopositive microglia, as counted on one tissue section. At the site of the clusters, no appar ent sign of tissue damage, hemorrhage, or neuronal cell death was present. The time of appearance of J Cereb Blood Flow Metab, Vol. 15, No.4, 1995 the cortical clusters corresponded to the onsei of glial APP expression in the hippocampus and the dorso lateral striatum.
DISCUSSION
Dementia of the Alzheimer type is a genetically heterogeneous disease (Schellenberg et aI. , 1992; Corder et aI. , 1993) that is neuropathologicaIly char acterized by the presence of �A4-amyloid contain ing plaques (Beyreuther and Masters, 1991) . As a considerable proportion of APP seems to be syn- thesized in glial cells (Banati et at. , 1993b; Busciglio et at. , 1993) , there is increasing evidence that the process of plaque formation reflects a chronic glial activation (Alzheimer, 19 I1; McGeer et at. , 1987; Wisniewski et aI. , 1989) . Such glial activation, pri marily of astrocytes and microglia, which might be accompanied by an increase in proteolytic activ ity, release of cytotoxic metabolites, and displace ment of synapses, is a common tissue reaction of the CNS in response to neuronal dysfunction and eventually neurodegeneration (Blinzinger and Kreutzberg, 1968; Graeber and Streit, 1990; Banati et aI. , 1991 Banati et aI. , -1993a Gehrmann et aI. , 1992c) . As a principally ubiquitous protein, inducible APP syn thesis has been reported for astrocytes (Siman et aI. , 1989; Haass et aI. , 1991) , microglia (Haass et aI. , 1991; LeBlanc et aI. , 1991; Konig et aI. , 1992; Monning et aI. , 1992; Banati et aI., 1993b) , and oli godendrocytes (Palacios et aI. , 1992) . The relative contribution of the different glial cell types to in creased total APP synthesis is, however, unclear. In comparatively mild forms of injury, without ob vious neuropathological tissue destruction and no cell death, as in the retrograde or anterograde neu ronal reactions after peripheral nerve axotomy, the lesion-induced APP synthesis seems to occur pri marily in activated microglia well before their trans formation into brain macrophages (Banati et aI. , 1993b) . Recent studies demonstrate de novo ex pression of APP after occlusion of the middle cere bral artery, leading to a focal cerebral infraction (Stephenson et aI. , 1992; Kalaria et aI. , 1993) . In this relatively severe lesion with blood-brain bar rier disruption, astrocytes seem the dominant APP-expressing glial element, while microglial macrophages appear to be prominent mainly in the immediate vicinity of the infarcted tissue. Unlike the occlusion of the middle cerebral artery, the four-vessel occlusion model employed in this study leads to global ischemia and to neuronal cell death in selectively vulnerable brain regions (Pulsinelli and Brierley, 1979; Schmidt-Kastner et aI. , 1989) .
In our study of the four-vessel occlusion mod e l of ischemia, we used the antibody 22C 11 (Boeh ringer), which specifically recognizes residues 66-81 of APP in mature as well as immature APP spe-cies with different degrees of glycosylation (Mon ning et aI. , 1992; Hilbich et aI. , 1993) , and the 2. F2. 18B4/APP 643-695/Jonas mouse monoclonal antibody (Boehringer) against the cytoplasmic car boxyl fragment of APP 643-695. Global ischemia rapidly induces a pronounced astrocytic and mi croglial expression of APP in the areas of neuronal cell death (Petito et aI. , 1990; Schmidt-Kastner et aI. , 1990; Gehrmann et aI. , 1992a,b) . Double label ing against APP and the specific glial epitopes GFAP or GSI-B4 revealed that in the hippocampal CAl and CA4 regions, APP expression is found largely in astrocytes and in only a relatively small number of microglia. The time course of APP ex pression in the hippocampus correlates with that of astrocytic GFAP expression, and in this model of global ischemia seems not to be preceded by a marked microglial APP expression. The described pattern of APP expression corresponds well to the cytoarchitecture of the hippocampus and differ ences in cellular responsiveness inherent to the postischemic hippocampus (Petito et aI. , 1990; Schmidt-Kastner et aI. , 1990) . Vol. 15, No.4, 1995 FIG. 4. Glial [f3-amyloid precursor protein] (APP) expression in the dorsolateral striatum (mouse monoclonal antibody 22C11). A: After ischemic lesion, immunoreactivity for APP was strongly induced in glial cells, preferentially in the border zone between the lesioned striatum and the surrounding tissue that shows no obvi ous sign of tissue damage. B: APP-expressing cells were mainly astrocytes but also microglia. Bar (A) = 50 f1m; bar (B) = 16 f1m.
In the cortex, small foci of activated microglia stained positively for APP. These clusters of APP immunopositive microglia in the parietal cortex are of particular interest. As neuronal cell loss in the cortex and a concomitant astrocytic reaction are known to occur (Lin et aI. , 1990) , the conspicuous presence of APP in activated microglia might indicate subtle neuronal damage in the parietal cortex. Microglia are regularly found in and around amyloid plaques (Alzheimer, 1911; McGeer et aI. , 1987; Wisniewski et aI. , 1989) . Interestingly, in their morphological structure, the postischemic, APP-expressing focal clusters of microglia resemble the very early amyloid-free "Verdichtung des Grundgewebes [condensation of tissue]" exten sively described by Alzheimer (1911). These were later described as "plaque A" or the "preamyloid," "diff use," and "amorphous" plaques frequently seen in the cortex of aged brains (Probst et aI. , 1991) .
Contrasting data have been reported concerning the neuronal APP regulation after nerve injury (Ba nati et aI. , 1993b) and global ischemia (Stephenson et aI. , 1992; Robison et aI. , 1993) . Levels of APP mRNA species not containing the KPI domain did not increase following global ischemia (Xie et aI., 1989; Abe et aI., 1991) . In contrast, an up-regulation of APP mRNA species with KPI is consistently found in focal and global ischemia (Wakita et aI., 1992; Heurteaux e! aI., 1993; Robison et aI., 1993) . As the differential APP mRNA splicing is cell type dependent and neurons do not express KPI-contain ing APP mRNA in considerable amounts (Weide mann et aI., 1989; Ohyagi et aI., 1990; Paul et aI., 1992) , it seems likely that most of the up-regulation of APP mRNA in these models is of glial origin. U sing the most extensively characterized monoclo nal antibodies against APP in our study, we could not detect any obvious up-regUlation of neuronal APP immunoreactivity. Differences from other studies might be due to the use of different antibod ies for APP detection. Though there is increasing evidence for glial de novo synthesis of APP (Haass et aI., 1991; LeBlanc et aI., 1991; Konig et aI., 1992; Monning et aI., 1992; Banati et aI., 1993b; Busciglio et at., 1993) , the antibodies used in this study allow no distinction between neuronal and nonneuronal APP. Nonetheless, our results indicate a crucial role of glial cells in the early metabolism of lesion induced APP, as either its producers or processors.
Hemodynamically important changes of blood vessels are found in most elderly people and partic ularly in patients with senile dementia (Wisniewski et aI., 1992; De la Torre and Mussivand, 1993) . Ischemic conditions in the brain, possibly on the background of genetic susceptibility (Citron et aI., 1992; Corder et aI., 1993) , might therefore be con tributory pathogenetic factors causing disturbed neuronal function and enhanced cerebral amy loidogenesis in patients diagnosed to have Alzhei mer's disease. Furthermore, congophilic angiopa thy is known to occur in � 10% of all patients suf fering from senile dementia of the Alzheimer type. In these patients, infarcts caused by the pro nounced vascular amyloid are frequent and patho physiologically important (Tomlinson, 1992) . In summary, we suggest that a pathological stimulus like global ischemia, a condition frequently ob served in elderly patients, also induces a nonneu ronal, i.e., glial, APP accumulation. According to the kind and severity of the cerebral lesion, regional differences in the glial APP regulation can be found.
